Atyr Pharma Inc
Research Atyr Pharma Inc (ATYR) on Bullrun: market cap USD 55.91M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerATYR
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 55.91M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 10.31M
- Free cash flow-USD 9.42M
Valuation Snapshot
latest market cap is USD 55.91M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 190.00K | -USD 74.12M | -USD 62.06M | n/a | -0.8 | USD 10.74M | USD 12.03M | USD 67.48M |
| FY2024 | USD 235.00K | -USD 64.02M | -USD 69.18M | n/a | -0.86 | USD 11.06M | USD 13.28M | USD 70.02M |
| FY2023 | USD 353.00K | -USD 50.39M | -USD 37.44M | n/a | -0.94 | USD 22.54M | USD 15.10M | USD 90.66M |
| FY2022 | USD 10.39M | -USD 45.34M | -USD 43.53M | n/a | -1.6 | USD 9.98M | n/a | USD 71.46M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 55.91M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 76.46M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 304.22M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 82.57M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 63.53M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 207.61M | n/a | n/a | n/a |
About Atyr Pharma Inc
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarcoidosis and systemic sclerosis- interstitial lung disease (ILDs);
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Atyr Pharma Inc's market cap?
Atyr Pharma Inc's market capitalization is USD 55.91M.
What does Atyr Pharma Inc do?
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.